Medicare Enrolled

Dr. George Lin, MD

Family Medicine · Hacienda Heights, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1850 S AZUSA AVE, Hacienda Heights, CA 91745
6269642880
In practice since 2006 (19 years)
NPI: 1679676035 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lin

Dr. George Lin is a family medicine specialist in Hacienda Heights, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lin performed 3,180 Medicare services across 737 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lin received a total of $27,316 from 41 pharmaceutical and/or device companies across 942 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 6% volume in CA $27,316 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,180
Medicare services
Top 6% in CA for family medicine
737
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~167 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,160 $18 $26
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
246 $8 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
236 $54 $118
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
108 $84 $95
Annual depression screening 103 $20 $30
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
98 $140 $185
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
76 $12 $45
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
50 $33 $36
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
48 $72 $76
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
19 $282 $299
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
19 $33 $37
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $82 $158
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$27,316
Total received (2018-2024)
Avg $3,902/year across 7 years
Top 1% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
942
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,019 (87.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,297 (12.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,825
2023
$4,136
2022
$3,575
2021
$3,713
2020
$2,245
2019
$7,130
2018
$2,692

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,024
Amgen Inc.
$813
GlaxoSmithKline, LLC.
$502
Gilead Sciences, Inc.
$283
Novo Nordisk Inc
$227
Lilly USA, LLC
$181
Merck Sharp & Dohme LLC
$142
AIMMUNE THERAPEUTICS, INC.
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
Novartis Pharmaceuticals Corporation
$88
PFIZER INC.
$84
Radius Health, Inc.
$79
Dexcom, Inc.
$75
Janssen Pharmaceuticals, Inc
$40
SHIELD THERAPEUTICS INC
$30
E.R. Squibb & Sons, L.L.C.
$22
Esperion Therapeutics, Inc.
$17
Top 3 companies account for 61.1% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$5,225
AstraZeneca Pharmaceuticals LP
$4,476
Amgen Inc.
$2,935
Novo Nordisk Inc
$2,478
Lilly USA, LLC
$2,026
GlaxoSmithKline, LLC.
$1,827
Janssen Pharmaceuticals, Inc
$1,688
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,305
Biohaven Pharmaceutical Holding Company Ltd.
$659
Dexcom, Inc.
$554
Merck Sharp & Dohme Corporation
$440
Amarin Pharma Inc.
$403
PFIZER INC.
$374
Novartis Pharmaceuticals Corporation
$222
Esperion Therapeutics, Inc.
$209
E.R. Squibb & Sons, L.L.C.
$203
ABBVIE INC.
$187
Bayer Healthcare Pharmaceuticals Inc.
$174
Otsuka America Pharmaceutical, Inc.
$163
ABIOMED
$160
Radius Health, Inc.
$159
Merck Sharp & Dohme LLC
$158
AbbVie Inc.
$150
Biohaven Pharmaceuticals, Inc.
$144
Bayer HealthCare Pharmaceuticals Inc.
$140
SANOFI-AVENTIS U.S. LLC
$134
Lexicon Pharmaceuticals, Inc.
$125
AIMMUNE THERAPEUTICS, INC.
$125
Boston Scientific Corporation
$104
Allergan, Inc.
$86
Almatica Pharma LLC
$48
SANOFI PASTEUR INC.
$42
Allergan Inc.
$37
SHIELD THERAPEUTICS INC
$30
Teva Pharmaceuticals USA, Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$22
Hologic, LLC
$21
Astellas Pharma US Inc
$17
ARBOR PHARMACEUTICALS, INC.
$15
RedHill Biopharma Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Top 3 companies account for 46.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADACEL · AIRSUPRA · AJOVY · ANORO · AREXVY · Aimovig · BEVESPI AEROSPHERE · BEXSERO · BOOSTRIX · BREO · BREZTRI · BREZTRI AEROSPHERE · COMIRNATY · DEXCOM G7 GSS (161) · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · GARDASIL · GARDASIL 9 · GRALISE · General - Tachy · INVOKANA · Impella · Inpefa · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINZESS · LOREEV XR · LYRICA · M-M-R II · MOUNJARO · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · REXULTI · REYVOW · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · THINPREP 2000 PROCESSOR · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Talicia · Tresiba · Trintellix · Tymlos · UBRELVY · VYNDAQEL · Vascepa · Vemlidy · Victoza · XARELTO · XIFAXAN · ZENPEP · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in CA.

Looking for a family medicine specialist in Hacienda Heights?
Compare family medicine physicians in the Hacienda Heights area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
3,784
Per 100K population
38.4
County median income
$87,760
Nearest hospital
PIH HEALTH HOSPITAL-WHITTIER
3.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lin is a mixed practice specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lin experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lin performed 2,160 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lin receive payments from pharmaceutical companies?
Yes. Dr. Lin received a total of $27,316 from 41 companies across 942 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lin's costs compare to other family medicine physicians in Hacienda Heights?
Dr. Lin's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →